CONSORT flow diagram for single-arm trials. por Jarad A. Lewellen (21213269)

“…The purpose of this single-arm, non-randomized, mixed-methods feasibility trial was to examine the feasibility of the Virtual Reality Education and Acceptance Protocol (VREAP), which was designed by the study’s authors to address barriers to VR adoption. …”

Exploring trainers' experiences of distance education at the South African military academy por Hendrik Jooste (22615124)

Materias:

الهجمات السيبرانيَّة وَفقًا لأحكام القانون الدولي الإنساني por Daraji, Mohammad Hasan

Materias: Enlace del recurso

التحليل القانوني لاستخدام الأسلحة الذكية في النزاعات المسلحة استنادًا إلى مبادئ القانون الدولي الإنساني... por Obaidat, Nour Abdel rahman Mahmoud

Materias: Enlace del recurso

Behavioural Response of <i>Sitophilus zeamais</i> to Essential Oil-Derived Compounds por Inês Sousa (14496491)

Materias:

Table 1_Efficacy and safety of flow diverters in small intracranial aneurysms: a systematic review and single-arm meta-analysis.docx por Kuerban Maimaitiaili (22686191)

Supplementary Figure 3 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma por Tom Wei-Wu Chen (15053003)

Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma por Tom Wei-Wu Chen (15053003)

Supplementary Table 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma por Tom Wei-Wu Chen (15053003)

Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma por Tom Wei-Wu Chen (15053003)

Supplementary Figure 4 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma por Tom Wei-Wu Chen (15053003)

العدالة الانتقالية في دول ما بعد الصراع: دول الربيع العربي نموذجًا por Abdelbaqi, Mustafa Hussein

Materias: Enlace del recurso

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer por Ulka N. Vaishampayan (15051039)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer por Ulka N. Vaishampayan (15051039)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer por Ulka N. Vaishampayan (15051039)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer por Ulka N. Vaishampayan (15051039)

“…<p>Shows the persistence of anti-CD3 x anti-HER2 bispecific antibody armed activated T cells (HER2 BATs) in the peripheral blood of two out of four patients.…”

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients por Javier Pascual (15018176)

“…PFS analysis in baseline population (C1D1) on TP53 mutations, by treatment arms.</p>…”

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models por Gonzalo Rodriguez-Berriguete (15056057)

“…The 6 Gy data points are replotted in a bar graph in <b>B</b> to allow better visual comparison between the different treatment arms (*, <i>P</i> < 0.05; **, <i>P</i> < 0.01; ***, <i>P</i> < 0.001; ****, <i>P</i> < 0.0001).…”

وقف المال الحرام وتطبيقاته المعاصرة: دراسة فقهية مقارنة por Shalah, Mohammad Motlaq Hamdan

Enlace del recurso

تجنيد المرأة في الشريعة الإسلامية الكويت نموذجًا por Al-Kandari, Mariam Ahmed Ali

Enlace del recurso